- Home
- NSPR vs TELA Comparison
NSPR vs TELA Comparison
Compare NSPR & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- TELA
- Stock Information
- Founded
- NSPR 2005
- TELA 2012
- Country
- NSPR Israel
- TELA United States
- Employees
- NSPR N/A
- TELA N/A
- Industry
- NSPR Medical/Dental Instruments
- TELA Medical/Dental Instruments
- Sector
- NSPR Health Care
- TELA Health Care
- Exchange
- NSPR Nasdaq
- TELA Nasdaq
- Market Cap
- NSPR 63.0M
- TELA 61.8M
- IPO Year
- NSPR N/A
- TELA 2019
- Fundamental
- Price
- NSPR $2.45
- TELA $3.07
- Analyst Decision
- NSPR Buy
- TELA Strong Buy
- Analyst Count
- NSPR 1
- TELA 4
- Target Price
- NSPR $4.50
- TELA $9.25
- AVG Volume (30 Days)
- NSPR 36.4K
- TELA 420.8K
- Earning Date
- NSPR 11-12-2024
- TELA 11-07-2024
- Dividend Yield
- NSPR N/A
- TELA N/A
- EPS Growth
- NSPR N/A
- TELA N/A
- EPS
- NSPR N/A
- TELA N/A
- Revenue
- NSPR $6,821,000.00
- TELA $68,649,000.00
- Revenue This Year
- NSPR $12.28
- TELA $30.39
- Revenue Next Year
- NSPR $53.44
- TELA $25.29
- P/E Ratio
- NSPR N/A
- TELA N/A
- Revenue Growth
- NSPR 24.70
- TELA 29.34
- 52 Week Low
- NSPR $1.81
- TELA $2.30
- 52 Week High
- NSPR $3.42
- TELA $7.84
- Technical
- Relative Strength Index (RSI)
- NSPR 61.14
- TELA 63.33
- Support Level
- NSPR $2.07
- TELA $2.90
- Resistance Level
- NSPR $3.05
- TELA $3.20
- Average True Range (ATR)
- NSPR 0.22
- TELA 0.18
- MACD
- NSPR 0.03
- TELA 0.03
- Stochastic Oscillator
- NSPR 63.92
- TELA 76.15
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About TELA TELA Bio Inc.
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.